MENU
+Compare
QLGN
Stock ticker: NASDAQ
AS OF
Sep 15, 04:57 PM (EDT)
Price
$2.03
Change
-$0.07 (-3.33%)
Capitalization
3.55M

QLGN Qualigen Therapeutics Inc Forecast, Technical & Fundamental Analysis

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer... Show more

QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for QLGN with price predictions
Sep 12, 2025

QLGN's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for QLGN turned positive on August 18, 2025. Looking at past instances where QLGN's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where QLGN's RSI Indicator exited the oversold zone, of 55 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 10, 2025. You may want to consider a long position or call options on QLGN as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where QLGN advanced for three days, in of 179 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QLGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

QLGN broke above its upper Bollinger Band on September 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for QLGN entered a downward trend on August 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (20.731). P/E Ratio (0.332) is within average values for comparable stocks, (53.474). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.171). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.382) is also within normal values, averaging (337.655).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. QLGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QLGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a biotechnology company which focused on developing therapeutics for the treatment of cancer and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5857 Owens Avenue
Phone
+1 760 452-8111
Employees
4
Web
https://www.qlgntx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDZN0.990.01
+0.92%
Roadzen
MP63.510.48
+0.76%
MP Materials Corp
IMXI14.50-0.02
-0.14%
International Money Express
VTAK2.45-0.05
-2.00%
Catheter Precision Inc
PSNY0.94-0.02
-2.27%
Polestar Automotive Holding UK PLC

QLGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with NTLA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
+0.24%
NTLA - QLGN
34%
Loosely correlated
N/A
PHIO - QLGN
32%
Poorly correlated
-6.03%
SABS - QLGN
29%
Poorly correlated
N/A
ZLDAF - QLGN
29%
Poorly correlated
N/A
MNOV - QLGN
28%
Poorly correlated
-1.60%
More